Nanosuspension-Based Dissolving Microneedle Arrays for Intradermal Delivery of Curcumin

被引:107
作者
Abdelghany, Sharif [1 ,2 ]
Tekko, Ismaiel A. [1 ,3 ]
Vora, Lalitkumar [1 ]
Larraneta, Eneko [1 ]
Permana, Andi Dian [1 ,4 ]
Donnelly, Ryan F. [1 ]
机构
[1] Queens Univ Belfast, Med Biol Ctr, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland
[2] Univ Jordan, Sch Pharm, Amman 11942, Jordan
[3] Aleppo Univ, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, POB 12212, Aleppo, Syria
[4] Hasanuddin Univ, Fac Pharm, Dept Pharmaceut, Makassar 90234, Indonesia
基金
英国惠康基金;
关键词
curcumin; dissolving microneedles; intradermal; poly(vinylalcohol); nanosuspension; I CLINICAL-TRIAL; TRANSDERMAL DELIVERY; SKIN; NANOPARTICLES; PENETRATION; BIOMARKERS; HYDROGELS; MODEL; TOOL;
D O I
10.3390/pharmaceutics11070308
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to evaluate the intradermal delivery of curcumin utilising poly(vinylalcohol) (PVA)-based microneedles loaded with curcumin nanosuspension (CU-NS). Nanoprecipitation was used to formulate the CU-NS which was then incorporated into PVA microneedles arrays consisting of 11 x 11 microneedles of conical shape, measuring 900 mu m in height and with 300 mu m base diameter. The nanosuspension particle size was 520 +/- 40 nm, with a polydispersity of 0.27 +/- 0.02 using sodium lauryl sulfate (SLS) as a stabiliser. In vitro dissolution studies in 10% w/v Tween 80 showed that the CU-NS dissolved significantly faster than unmodified curcumin powder, with 34% released from the CU-NS, compared to 16% from the curcumin powder after 48 h. The CU-NS-loaded microneedles (CU-MN) were able to withstand a compression force of 32 N for 30 s. Moreover, these microneedles were able to penetrate excised neonatal porcine skin to a depth of 500 mu m, dissolved completely in the skin within 60 min. After CU-MN dissolution, the drug diffused from the application site and migrated through the skin layers down to 2300 mu m, significantly more than observed with topical application of CU-NS. This suggest that the fabricated microneedles with the incorporated CU-NS could enhance the intradermal delivery of curcumin.
引用
收藏
页数:13
相关论文
共 40 条
  • [31] Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance
    Sharma, RA
    Euden, SA
    Platton, SL
    Cooke, DN
    Shafayat, A
    Hewitt, HR
    Marczylo, TH
    Morgan, B
    Hemingway, D
    Plummer, SM
    Pirmohamed, M
    Gescher, AJ
    Steward, WP
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6847 - 6854
  • [32] Singh Thakur R R, 2010, Recent Pat Drug Deliv Formul, V4, P1
  • [33] Topical Curcumin-Based CreamIs Equivalent to Dietary Curcumin in a Skin Cancer Model
    Sonavane, Kunal
    Phillips, Jeffrey
    Ekshyyan, Oleksandr
    Moore-Medlin, Tara
    Gill, Jennifer Roberts
    Rong, Xiaohua
    Lakshmaiah, Raghunatha Reddy
    Abreo, Fleurette
    Boudreaux, Douglas
    Clifford, John L.
    Nathan, Cherie-Ann O.
    [J]. JOURNAL OF SKIN CANCER, 2012, 2012
  • [34] Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery
    Stoner, CL
    Cleton, A
    Johnson, K
    Oh, DM
    Hallak, H
    Brodfuehrer, J
    Surendran, N
    Han, HK
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) : 241 - 249
  • [35] Minimally invasive protein delivery with rapidly dissolving polymer microneedles
    Sullivan, Sean P.
    Murthy, Niren
    Prausnitz, Mark R.
    [J]. ADVANCED MATERIALS, 2008, 20 (05) : 933 - +
  • [36] The immunology of the porcine skin and its value as a model for human skin
    Surnmerfield, Artur
    Meurens, Francois
    Ricklin, Meret E.
    [J]. MOLECULAR IMMUNOLOGY, 2015, 66 (01) : 14 - 21
  • [37] Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo
    Vicente-Perez, Eva M.
    Larraneta, Eneko
    McCrudden, Maeliosa T. C.
    Kissenpfennig, Adrien
    Hegarty, Shauna
    McCarthy, Helen O.
    Donnelly, Ryan F.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 117 : 400 - 407
  • [38] Vora Lalit K, 2018, J Interdiscip Nanomed, V3, P89, DOI 10.1002/jin2.41
  • [39] Novel bilayer dissolving microneedle arrays with concentrated PLGA nanomicroparticles for targeted intradermal delivery: Proof of concept
    Vora, Lalit K.
    Donnelly, Ryan F.
    Larraneta, Eneko
    Gonzalez-Vazquez, Patricia
    Thakur, Raghu Raj Singh
    Vavia, Pradeep R.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2017, 265 : 93 - 101
  • [40] Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles
    Zhang, Wei
    Gao, Jing
    Zhu, Quangang
    Zhang, Min
    Ding, Xueying
    Wang, Xiaoyu
    Hou, Xuemei
    Fan, Wei
    Ding, Baoyue
    Wu, Xin
    Wang, Xiying
    Gao, Shen
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 402 (1-2) : 205 - 212